Revealing the Mechanism of Huazhi Rougan Granule in the Treatment of Nonalcoholic Fatty Liver Through Intestinal Flora Based on 16S rRNA, Metagenomic Sequencing and Network Pharmacology

Background: The incidence of Nonalcoholic Fatty Liver (NAFL) is increasing year by year, growing evidence suggests that the intestinal flora plays a causative role in NAFL. Huazhi Rougan Granule (HRG) is commonly used in the clinical treatment of NAFL. It is reported that it can reduce lipids and pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yingying, Tan, Yingying, Huang, Jiaqi, Wu, Chao, Fan, Xiaotian, Stalin, Antony, Lu, Shan, Wang, Haojia, Zhang, Jingyuan, Zhang, Fanqin, Wu, Zhishan, Li, Bing, Huang, Zhihong, Chen, Meilin, Cheng, Guoliang, Mou, Yanfang, Wu, Jiarui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086680/
https://www.ncbi.nlm.nih.gov/pubmed/35559233
http://dx.doi.org/10.3389/fphar.2022.875700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086680/
https://www.ncbi.nlm.nih.gov/pubmed/35559233
http://dx.doi.org/10.3389/fphar.2022.875700

Ejemplares similares